[New in conservative therapy of chronic sialoadenitis].
The use of vasaprostan nucellary form in complex treatment of patients with chronic parenchymatous sialoadenitis in a stage of an aggravation in the field of amazed salivary gland renders good therapeutic effect, which is proved by clinical data and results of reografic and bioсemical researches (laktoferrin concentration, middlemolecularpeptids and sum of primary and secondary products of hyperoxide acidification lipids, basis of Shiff).
U R
UR
Mirzakulova
D000328:Adult; D000527:Alprostadil / Q000008:administration & dosage / Q000627:therapeutic use*; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007781:Lactoferrin / Q000032:analysis; D015227:Lipid Peroxidation; D008297:Male; D008823:Micelles; D008875:Middle Aged; D010455:Peptides / Q000032:analysis; D012469:Salivary Glands / Q000187:drug effects*; D012545:Schiff Bases / Q000032:analysis; D012793:Sialadenitis / Q000188:drug therapy*; D016896:Treatment Outcome; D055815:Young Adult
D000975:Antioxidants; D008823:Micelles; D010455:Peptides; D012545:Schiff Bases; C082171:lactoferricin B; D007781:Lactoferrin; D000527:Alprostadil